CARERX CORP (CRRX.CA) Fundamental Analysis & Valuation

TSX:CRRX • CA14173C1059

Current stock price

3.82 CAD
0 (0%)
Last:

This CRRX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CRRX.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CRRX was profitable.
  • In the past year CRRX had a positive cash flow from operations.
  • In the past 5 years CRRX reported 4 times negative net income.
  • Each year in the past 5 years CRRX had a positive operating cash flow.
CRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFCRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • With an excellent Return On Assets value of 10.75%, CRRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • With a decent Return On Equity value of 23.86%, CRRX is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • With a Return On Invested Capital value of 4.76%, CRRX is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
  • The Average Return On Invested Capital over the past 3 years for CRRX is significantly below the industry average of 11.21%.
  • The 3 year average ROIC (3.72%) for CRRX is below the current ROIC(4.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.75%
ROE 23.86%
ROIC 4.76%
ROA(3y)2.14%
ROA(5y)-2.92%
ROE(3y)3.96%
ROE(5y)-13.81%
ROIC(3y)3.72%
ROIC(5y)3.08%
CRRX.CA Yearly ROA, ROE, ROICCRRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

  • CRRX's Profit Margin of 7.06% is amongst the best of the industry. CRRX outperforms 100.00% of its industry peers.
  • CRRX has a Operating Margin of 3.21%. This is in the lower half of the industry: CRRX underperforms 75.00% of its industry peers.
  • In the last couple of years the Operating Margin of CRRX has grown nicely.
  • CRRX's Gross Margin of 29.97% is on the low side compared to the rest of the industry. CRRX is outperformed by 62.50% of its industry peers.
  • CRRX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.21%
PM (TTM) 7.06%
GM 29.97%
OM growth 3Y17.08%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y0.63%
CRRX.CA Yearly Profit, Operating, Gross MarginsCRRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

4

2. CRRX.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRRX is destroying value.
  • Compared to 1 year ago, CRRX has more shares outstanding
  • CRRX has more shares outstanding than it did 5 years ago.
  • CRRX has a better debt/assets ratio than last year.
CRRX.CA Yearly Shares OutstandingCRRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CRRX.CA Yearly Total Debt VS Total AssetsCRRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of 1.26, we must say that CRRX is in the distress zone and has some risk of bankruptcy.
  • CRRX's Altman-Z score of 1.26 is on the low side compared to the rest of the industry. CRRX is outperformed by 87.50% of its industry peers.
  • CRRX has a debt to FCF ratio of 3.46. This is a good value and a sign of high solvency as CRRX would need 3.46 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.46, CRRX belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
  • A Debt/Equity ratio of 0.64 indicates that CRRX is somewhat dependend on debt financing.
  • CRRX's Debt to Equity ratio of 0.64 is amongst the best of the industry. CRRX outperforms 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.46
Altman-Z 1.26
ROIC/WACC0.71
WACC6.68%
CRRX.CA Yearly LT Debt VS Equity VS FCFCRRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that CRRX should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.06, CRRX is doing worse than 81.25% of the companies in the same industry.
  • CRRX has a Quick Ratio of 1.06. This is a bad value and indicates that CRRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CRRX has a better Quick ratio (0.78) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.78
CRRX.CA Yearly Current Assets VS Current LiabilitesCRRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. CRRX.CA Growth Analysis

3.1 Past

  • CRRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 685.71%, which is quite impressive.
  • Looking at the last year, CRRX shows a small growth in Revenue. The Revenue has grown by 0.96% in the last year.
  • Measured over the past years, CRRX shows a quite strong growth in Revenue. The Revenue has been growing by 17.95% on average per year.
EPS 1Y (TTM)685.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1366.67%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y-1.01%
Revenue growth 5Y17.95%
Sales Q2Q%4.23%

3.2 Future

  • The Earnings Per Share is expected to decrease by -21.14% on average over the next years. This is quite bad
  • Based on estimates for the next years, CRRX will show a small growth in Revenue. The Revenue will grow by 5.81% on average per year.
EPS Next Y-55.22%
EPS Next 2Y-21.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7%
Revenue Next 2Y5.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRRX.CA Yearly Revenue VS EstimatesCRRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRRX.CA Yearly EPS VS EstimatesCRRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

3

4. CRRX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.32, the valuation of CRRX can be described as reasonable.
  • Based on the Price/Earnings ratio, CRRX is valued a bit cheaper than 75.00% of the companies in the same industry.
  • CRRX is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 20.81 indicates a rather expensive valuation of CRRX.
  • CRRX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRRX is more expensive than 62.50% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CRRX to the average of the S&P500 Index (22.19), we can say CRRX is valued inline with the index average.
Industry RankSector Rank
PE 9.32
Fwd PE 20.81
CRRX.CA Price Earnings VS Forward Price EarningsCRRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRRX indicates a slightly more expensive valuation: CRRX is more expensive than 62.50% of the companies listed in the same industry.
  • CRRX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 10.65
EV/EBITDA 10.06
CRRX.CA Per share dataCRRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • CRRX's earnings are expected to decrease with -21.14% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.14%
EPS Next 3YN/A

3

5. CRRX.CA Dividend Analysis

5.1 Amount

  • CRRX has a Yearly Dividend Yield of 2.09%. Purely for dividend investing, there may be better candidates out there.
  • CRRX's Dividend Yield is a higher than the industry average which is at 2.39.
  • Compared to an average S&P500 Dividend Yield of 1.89, CRRX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

  • CRRX is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRRX.CA Yearly Dividends per shareCRRX.CA Yearly Dividends per shareYearly Dividends per share 2025 2026 0 0 0 0 0

5.3 Sustainability

  • 4.82% of the earnings are spent on dividend by CRRX. This is a low number and sustainable payout ratio.
DP4.82%
EPS Next 2Y-21.14%
EPS Next 3YN/A
CRRX.CA Yearly Income VS Free CF VS DividendCRRX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M
CRRX.CA Dividend Payout.CRRX.CA Dividend Payout, showing the Payout Ratio.CRRX.CA Dividend Payout.PayoutRetained Earnings

CRRX.CA Fundamentals: All Metrics, Ratios and Statistics

CARERX CORP

TSX:CRRX (3/27/2026, 7:00:00 PM)

3.82

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners46.78%
Inst Owner ChangeN/A
Ins Owners10.89%
Ins Owner ChangeN/A
Market Cap239.86M
Revenue(TTM)370.24M
Net Income(TTM)26.13M
Analysts81.82
Price Target5.48 (43.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP4.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-19
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)870.59%
Min EPS beat(2)-21.57%
Max EPS beat(2)1762.75%
EPS beat(4)1
Avg EPS beat(4)409.8%
Min EPS beat(4)-100%
Max EPS beat(4)1762.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.14%
Max Revenue beat(2)-1.13%
Revenue beat(4)0
Avg Revenue beat(4)-2.36%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-1.13%
Revenue beat(8)0
Avg Revenue beat(8)-1.87%
Revenue beat(12)0
Avg Revenue beat(12)-2.35%
Revenue beat(16)2
Avg Revenue beat(16)-1.82%
PT rev (1m)7.5%
PT rev (3m)10.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-6.25%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 9.32
Fwd PE 20.81
P/S 0.65
P/FCF 10.65
P/OCF 7.78
P/B 2.19
P/tB 22.62
EV/EBITDA 10.06
EPS(TTM)0.41
EY10.73%
EPS(NY)0.18
Fwd EY4.81%
FCF(TTM)0.36
FCFY9.39%
OCF(TTM)0.49
OCFY12.85%
SpS5.9
BVpS1.74
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.01
Profitability
Industry RankSector Rank
ROA 10.75%
ROE 23.86%
ROCE 6.6%
ROIC 4.76%
ROICexc 5.15%
ROICexgc 12.75%
OM 3.21%
PM (TTM) 7.06%
GM 29.97%
FCFM 6.08%
ROA(3y)2.14%
ROA(5y)-2.92%
ROE(3y)3.96%
ROE(5y)-13.81%
ROIC(3y)3.72%
ROIC(5y)3.08%
ROICexc(3y)3.97%
ROICexc(5y)3.37%
ROICexgc(3y)11.64%
ROICexgc(5y)10.67%
ROCE(3y)5.17%
ROCE(5y)4.28%
ROICexgc growth 3Y4.59%
ROICexgc growth 5YN/A
ROICexc growth 3Y17.34%
ROICexc growth 5YN/A
OM growth 3Y17.08%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.34%
GM growth 5Y0.63%
F-Score8
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 3.46
Debt/EBITDA 2.32
Cap/Depr 45.26%
Cap/Sales 2.24%
Interest Coverage 3.63
Cash Conversion 101.98%
Profit Quality 86.18%
Current Ratio 1.06
Quick Ratio 0.78
Altman-Z 1.26
F-Score8
WACC6.68%
ROIC/WACC0.71
Cap/Depr(3y)43.69%
Cap/Depr(5y)49.03%
Cap/Sales(3y)2.27%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)685.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1366.67%
EPS Next Y-55.22%
EPS Next 2Y-21.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.96%
Revenue growth 3Y-1.01%
Revenue growth 5Y17.95%
Sales Q2Q%4.23%
Revenue Next Year7%
Revenue Next 2Y5.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.4%
EBIT growth 3Y15.9%
EBIT growth 5YN/A
EBIT Next Year230.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.64%
FCF growth 3Y37.19%
FCF growth 5YN/A
OCF growth 1Y-18.89%
OCF growth 3Y11.33%
OCF growth 5Y166.32%

CARERX CORP / CRRX.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CARERX CORP?

ChartMill assigns a fundamental rating of 4 / 10 to CRRX.CA.


What is the valuation status for CRRX stock?

ChartMill assigns a valuation rating of 3 / 10 to CARERX CORP (CRRX.CA). This can be considered as Overvalued.


How profitable is CARERX CORP (CRRX.CA) stock?

CARERX CORP (CRRX.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CRRX stock?

The Price/Earnings (PE) ratio for CARERX CORP (CRRX.CA) is 9.32 and the Price/Book (PB) ratio is 2.19.


How financially healthy is CARERX CORP?

The financial health rating of CARERX CORP (CRRX.CA) is 4 / 10.